首页 > 最新文献

Focus (American Psychiatric Publishing)最新文献

英文 中文
Why Teens Don't Talk: Understanding the Role of Stigma Within Barriers to Help Seeking. 为什么青少年不说话:理解耻辱在寻求帮助障碍中的作用。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.1176/appi.focus.20240029
Kamla Modi, Michelle G Mullen, Kristia Tolode, Laura Erickson-Schroth, Katie Hurley, John MacPhee

The stigma of mental illness, among a larger set of barriers to help seeking, has been understudied among teens. These barriers and the sources of support were examined through an online survey with 1,428 U.S. 13- to 17-year-olds. Data were analyzed using Q, with indexing and Z tests calculated for significant group differences. Parents were cited as the top support source for depression compared with mental health professionals. Nonstigma barriers were the top barriers for teens, including discomfort with difficult emotions and being misunderstood when reaching out for support. Stigma barriers were significantly higher for Hispanic and LGBTQ+ teens, and stigma-adjacent barriers were significantly higher among Black/African American teens. Results are discussed in terms of the differential support that teens need to navigate emotional challenges and for further understanding barriers to help seeking that are not weighed heavily by stigma, as in past studies.

在青少年寻求帮助的诸多障碍中,精神疾病的耻辱感一直没有得到充分的研究。通过对1428名13至17岁的美国青少年进行在线调查,研究人员对这些障碍和支持来源进行了调查。数据用Q进行分析,用索引检验和Z检验计算显著组间差异。与心理健康专家相比,父母被认为是抑郁症的最大支持来源。非污名化障碍是青少年面临的最大障碍,包括对困难情绪的不适,以及在寻求支持时被误解。西班牙裔和LGBTQ+青少年的耻辱感障碍显著更高,黑人/非裔青少年的耻辱感障碍显著更高。研究结果讨论了青少年应对情感挑战所需的不同支持,以及进一步了解寻求帮助的障碍,这些障碍不像过去的研究那样被污名所严重影响。
{"title":"Why Teens Don't Talk: Understanding the Role of Stigma Within Barriers to Help Seeking.","authors":"Kamla Modi, Michelle G Mullen, Kristia Tolode, Laura Erickson-Schroth, Katie Hurley, John MacPhee","doi":"10.1176/appi.focus.20240029","DOIUrl":"10.1176/appi.focus.20240029","url":null,"abstract":"<p><p>The stigma of mental illness, among a larger set of barriers to help seeking, has been understudied among teens. These barriers and the sources of support were examined through an online survey with 1,428 U.S. 13- to 17-year-olds. Data were analyzed using <i>Q</i>, with indexing and <i>Z</i> tests calculated for significant group differences. Parents were cited as the top support source for depression compared with mental health professionals. Nonstigma barriers were the top barriers for teens, including discomfort with difficult emotions and being misunderstood when reaching out for support. Stigma barriers were significantly higher for Hispanic and LGBTQ+ teens, and stigma-adjacent barriers were significantly higher among Black/African American teens. Results are discussed in terms of the differential support that teens need to navigate emotional challenges and for further understanding barriers to help seeking that are not weighed heavily by stigma, as in past studies.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"23 1","pages":"25-32"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weight Stigma in Medicine. 医学中的体重病耻感。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.1176/appi.focus.20240031
Jennifer L Derenne
{"title":"Weight Stigma in Medicine.","authors":"Jennifer L Derenne","doi":"10.1176/appi.focus.20240031","DOIUrl":"10.1176/appi.focus.20240031","url":null,"abstract":"","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"23 1","pages":"49-52"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microaggressions and Cultural Ruptures in Psychiatry: Extending Multicultural Counseling Orientation to Psychiatric Services. 精神病学中的微侵犯与文化断裂:将多元文化咨询导向扩展到精神病学服务。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.1176/appi.focus.20240034
Brendalisse Rudecindo, Patty Kuo, William A Smith, Karen W Tao, Zachary E Imel

Racial microaggressions and cultural ruptures have a significant impact on mental health care for Black, Indigenous, and people of color (BIPOC) communities. This article reviews the application of the multicultural counseling orientation framework in psychiatry to address these challenges and improve therapeutic outcomes. The authors outline strategies to integrate cultural humility into psychiatric practice, with an emphasis on self-reflection, feedback, and the recognition of microaggressions. By fostering cultural humility, providers can create therapeutic spaces where patients feel safe and validated. The article also discusses cultural opportunities for exploring patients' identities and advocates for open dialogue that addresses these aspects early in treatment. Structural recommendations include enhancing training programs to incorporate equity-focused coursework, promoting recruitment and retention of BIPOC clinicians, and developing institutional policies to address systemic inequities. Adopting these approaches can reduce the adverse effects of microaggressions, build trust, and improve mental health outcomes for BIPOC patients. The authors suggest that future efforts should emphasize systemic changes in training, recruitment, and community engagement to create a more inclusive mental health care system.

种族微侵犯和文化破裂对黑人、土著和有色人种(BIPOC)社区的精神卫生保健产生了重大影响。本文回顾了多元文化咨询取向框架在精神病学中的应用,以应对这些挑战并改善治疗结果。作者概述了将文化谦逊融入精神病学实践的策略,强调自我反思、反馈和对微侵犯的识别。通过培养谦逊的文化,提供者可以创造治疗空间,让患者感到安全和认可。文章还讨论了探索患者身份的文化机会,并倡导在治疗早期就这些方面进行公开对话。结构性建议包括加强培训计划,纳入以公平为重点的课程,促进BIPOC临床医生的招聘和保留,以及制定制度政策以解决系统性不平等问题。采用这些方法可以减少微侵犯的不良影响,建立信任,并改善BIPOC患者的心理健康结果。作者建议,未来的努力应强调培训、招聘和社区参与方面的系统性变革,以创建一个更具包容性的精神卫生保健系统。
{"title":"Microaggressions and Cultural Ruptures in Psychiatry: Extending Multicultural Counseling Orientation to Psychiatric Services.","authors":"Brendalisse Rudecindo, Patty Kuo, William A Smith, Karen W Tao, Zachary E Imel","doi":"10.1176/appi.focus.20240034","DOIUrl":"10.1176/appi.focus.20240034","url":null,"abstract":"<p><p>Racial microaggressions and cultural ruptures have a significant impact on mental health care for Black, Indigenous, and people of color (BIPOC) communities. This article reviews the application of the multicultural counseling orientation framework in psychiatry to address these challenges and improve therapeutic outcomes. The authors outline strategies to integrate cultural humility into psychiatric practice, with an emphasis on self-reflection, feedback, and the recognition of microaggressions. By fostering cultural humility, providers can create therapeutic spaces where patients feel safe and validated. The article also discusses cultural opportunities for exploring patients' identities and advocates for open dialogue that addresses these aspects early in treatment. Structural recommendations include enhancing training programs to incorporate equity-focused coursework, promoting recruitment and retention of BIPOC clinicians, and developing institutional policies to address systemic inequities. Adopting these approaches can reduce the adverse effects of microaggressions, build trust, and improve mental health outcomes for BIPOC patients. The authors suggest that future efforts should emphasize systemic changes in training, recruitment, and community engagement to create a more inclusive mental health care system.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"23 1","pages":"9-18"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Support People to Seek Mental Health Help. 如何支持人们寻求精神健康帮助。
Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.1176/appi.focus.20240038
Kenneth Duckworth, Nikki Rashes
{"title":"How to Support People to Seek Mental Health Help.","authors":"Kenneth Duckworth, Nikki Rashes","doi":"10.1176/appi.focus.20240038","DOIUrl":"10.1176/appi.focus.20240038","url":null,"abstract":"","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"23 1","pages":"53-54"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safeguarding Futures: Innovations in Substance Use Prevention. 保护未来:药物使用预防的创新。
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.20240037
Katia Delrahim Howlett
{"title":"Safeguarding Futures: Innovations in Substance Use Prevention.","authors":"Katia Delrahim Howlett","doi":"10.1176/appi.focus.20240037","DOIUrl":"10.1176/appi.focus.20240037","url":null,"abstract":"","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"433"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing Substance Use and Overdose Among Young Adults: The Role of Social Determinants of Health. 预防青少年使用药物和用药过量:健康的社会决定因素的作用》。
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.20240022
Christopher M Jones

The United States is in the midst of an evolving overdose crisis, driven by the proliferation of potent synthetic opioids (e.g., illicitly made fentanyl), the resurgence of stimulants (e.g., methamphetamine), and the introduction of adulterants (e.g., xylazine) into the illicit drug supply. These substance use challenges are happening against the backdrop of rising mental health challenges that are closely linked to substance use and overdose. As overdose deaths have increased, the demographic profile of those dying has shifted and now disproportionately affects certain racial and ethnic minority populations. Social determinants of health (SDOH) are an underexplored component of the prevention response but are particularly salient in addressing substance use and overdose. Many SDOH have been linked to an increased risk for substance use and overdose, either directly or indirectly. The author examines the connection between SDOH and substance use and overdose, with a particular focus on young adults.

在强效合成类阿片(如非法制造的芬太尼)的扩散、兴奋剂(如甲基苯丙胺)的死灰复燃以及非法药物供应中掺杂掺假(如甲苯噻嗪)等因素的推动下,美国正处于不断演变的用药过量危机之中。这些药物使用方面的挑战是在精神健康挑战不断增加的背景下出现的,而精神健康挑战与药物使用和用药过量密切相关。随着用药过量死亡人数的增加,死亡者的人口结构也发生了变化,现在某些种族和少数民族人口受到的影响尤为严重。健康的社会决定因素(SDOH)是预防对策中一个未被充分开发的组成部分,但在解决药物使用和用药过量问题时尤为突出。许多社会决定性健康因素都直接或间接地与药物使用和用药过量风险增加有关。作者研究了 SDOH 与药物使用和用药过量之间的联系,尤其关注青壮年。
{"title":"Preventing Substance Use and Overdose Among Young Adults: The Role of Social Determinants of Health.","authors":"Christopher M Jones","doi":"10.1176/appi.focus.20240022","DOIUrl":"10.1176/appi.focus.20240022","url":null,"abstract":"<p><p>The United States is in the midst of an evolving overdose crisis, driven by the proliferation of potent synthetic opioids (e.g., illicitly made fentanyl), the resurgence of stimulants (e.g., methamphetamine), and the introduction of adulterants (e.g., xylazine) into the illicit drug supply. These substance use challenges are happening against the backdrop of rising mental health challenges that are closely linked to substance use and overdose. As overdose deaths have increased, the demographic profile of those dying has shifted and now disproportionately affects certain racial and ethnic minority populations. Social determinants of health (SDOH) are an underexplored component of the prevention response but are particularly salient in addressing substance use and overdose. Many SDOH have been linked to an increased risk for substance use and overdose, either directly or indirectly. The author examines the connection between SDOH and substance use and overdose, with a particular focus on young adults.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"474-482"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Family-Focused Prevention and Early Intervention of Substance Use in Pediatric Primary Care Settings. 以家庭为重点的儿科初级保健中药物使用的预防和早期干预。
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.20240026
Pamela A Matson, Jessica B Calihan, Sarah M Bagley, Hoover Adger

Prevention of substance misuse and substance use disorders is a national public health priority. The home environment can represent risk or protective factors for development of substance misuse. Children in homes with caregiver substance use are biologically, developmentally, interpersonally, and environmentally vulnerable to substance misuse and associated consequences, making it necessary for substance use prevention to focus on families early. Children and families who are minoritized, marginalized, and disenfranchised experience disproportionate consequences of substance use, through experiences of poverty, racism, trauma, and the built environment. Strengthening protective factors in early childhood by improving the health of caregivers and supporting the caregiver-child relationship can have enduring benefits over the life course. Pediatric primary care practices are an important setting for adopting a family-focused approach to prevention and early intervention of substance use. By engaging families early, identifying substance use in the family and household, recognizing the intersection of social needs and substance use, providing culturally tailored, trauma-informed, evidence-based care, and advising and supporting families on ways to minimize substance-related harm, pediatric care providers can play an important role in preventing substance use and substance-related consequences to children and families. Pediatric care providers are ideally suited to deliver prevention messages in a nonstigmatizing manner and serve as a conduit to evidence-based, family-focused intervention programs.

预防药物滥用和药物使用失调是国家公共卫生的优先事项。家庭环境可能是导致药物滥用的风险因素,也可能是保护因素。在照顾者使用药物的家庭中,儿童在生理、发育、人际和环境方面都很容易出现药物滥用及相关后果,因此有必要及早将药物使用预防工作的重点放在家庭上。由于贫穷、种族主义、心理创伤和建筑环境的影响,那些被少数化、边缘化和剥夺权利的儿童和家庭会经历过多的药物使用后果。通过改善照顾者的健康状况和支持照顾者与儿童之间的关系来加强幼儿期的保护性因素,可以在整个生命过程中产生持久的益处。儿科初级保健实践是采用以家庭为中心的方法预防和早期干预药物使用的重要环境。通过尽早让家庭参与进来,识别家庭中的药物使用情况,认识到社会需求与药物使用的交叉点,提供文化定制、创伤知情、循证护理,并就如何最大限度地减少药物相关伤害向家庭提供建议和支持,儿科护理提供者可以在预防药物使用以及药物相关后果对儿童和家庭的影响方面发挥重要作用。儿科护理提供者非常适合以非污名化的方式传递预防信息,并充当以证据为基础、以家庭为重点的干预计划的渠道。
{"title":"Family-Focused Prevention and Early Intervention of Substance Use in Pediatric Primary Care Settings.","authors":"Pamela A Matson, Jessica B Calihan, Sarah M Bagley, Hoover Adger","doi":"10.1176/appi.focus.20240026","DOIUrl":"10.1176/appi.focus.20240026","url":null,"abstract":"<p><p>Prevention of substance misuse and substance use disorders is a national public health priority. The home environment can represent risk or protective factors for development of substance misuse. Children in homes with caregiver substance use are biologically, developmentally, interpersonally, and environmentally vulnerable to substance misuse and associated consequences, making it necessary for substance use prevention to focus on families early. Children and families who are minoritized, marginalized, and disenfranchised experience disproportionate consequences of substance use, through experiences of poverty, racism, trauma, and the built environment. Strengthening protective factors in early childhood by improving the health of caregivers and supporting the caregiver-child relationship can have enduring benefits over the life course. Pediatric primary care practices are an important setting for adopting a family-focused approach to prevention and early intervention of substance use. By engaging families early, identifying substance use in the family and household, recognizing the intersection of social needs and substance use, providing culturally tailored, trauma-informed, evidence-based care, and advising and supporting families on ways to minimize substance-related harm, pediatric care providers can play an important role in preventing substance use and substance-related consequences to children and families. Pediatric care providers are ideally suited to deliver prevention messages in a nonstigmatizing manner and serve as a conduit to evidence-based, family-focused intervention programs.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"464-473"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Impairment and Dose Adjustment of Long-Acting Injectable Antipsychotics: Are We Getting It Right? A Case Report. 肾功能损害与长效注射用抗精神病药物的剂量调整:我们做对了吗?病例报告。
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.20240007
Colette Raphaël, Gary Remington, Ofer Agid

Renal impairment is defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 with or without kidney damage. Creatinine, which is found in serum and urine, is a common biomarker to estimate renal function and is used in most eGFR equations. Renal impairment can decrease or increase drug effects, necessitating therapeutic adjustments. Increased effect is related to drug accumulation that leads to increased elimination time and potential toxicity. eGFR plays a crucial role in drug dosing, particularly for renally excreted medications. However, the lack of recognition of pre-existing renal impairment and the incorrect interpretation of eGFR equations remain challenges. This case report explores the significance of eGFR in patients with psychiatric conditions, especially in the context of long-acting antipsychotic drug dosing.

肾功能损害是指估计肾小球滤过率(eGFR)为 2,伴有或不伴有肾脏损害。肌酐存在于血清和尿液中,是估算肾功能的常用生物标志物,被用于大多数 eGFR 方程中。肾功能损害会降低或增加药物疗效,因此需要调整治疗方案。药效增加与药物蓄积有关,药物蓄积会导致排出时间延长和潜在毒性增加。eGFR 在用药剂量中起着至关重要的作用,特别是对于经肾排泄的药物。然而,缺乏对原有肾功能损害的认识以及对 eGFR 方程的错误解释仍然是一项挑战。本病例报告探讨了 eGFR 在精神病患者中的重要性,尤其是在长效抗精神病药物剂量方面。
{"title":"Renal Impairment and Dose Adjustment of Long-Acting Injectable Antipsychotics: Are We Getting It Right? A Case Report.","authors":"Colette Raphaël, Gary Remington, Ofer Agid","doi":"10.1176/appi.focus.20240007","DOIUrl":"10.1176/appi.focus.20240007","url":null,"abstract":"<p><p><i>Renal impairment</i> is defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m<sup>2</sup> with or without kidney damage. Creatinine, which is found in serum and urine, is a common biomarker to estimate renal function and is used in most eGFR equations. Renal impairment can decrease or increase drug effects, necessitating therapeutic adjustments. Increased effect is related to drug accumulation that leads to increased elimination time and potential toxicity. eGFR plays a crucial role in drug dosing, particularly for renally excreted medications. However, the lack of recognition of pre-existing renal impairment and the incorrect interpretation of eGFR equations remain challenges. This case report explores the significance of eGFR in patients with psychiatric conditions, especially in the context of long-acting antipsychotic drug dosing.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"492-494"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Stigmas That Hinder Addiction Treatment and Recovery. 消除妨碍戒毒和康复的污名。
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.20240023
Dorothy E Stubbe
{"title":"Addressing Stigmas That Hinder Addiction Treatment and Recovery.","authors":"Dorothy E Stubbe","doi":"10.1176/appi.focus.20240023","DOIUrl":"10.1176/appi.focus.20240023","url":null,"abstract":"","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"501-504"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A National Strategy for Preventing Substance and Opioid Use Disorders Through Evidence-Based Prevention Programming That Fosters Healthy Outcomes in Our Youth. 通过以证据为基础的预防计划来预防药物和阿片类药物使用失调,从而促进青少年健康成长的国家战略》(A National Strategy for Preventing Substance and Opioid Use Disorders Through Evidence-Based Prevention Programming that Fosters Healthy Outcomes in Our Youth.
Pub Date : 2024-10-01 Epub Date: 2024-10-15 DOI: 10.1176/appi.focus.24022020
Diana H Fishbein, Zili Sloboda

The recently released National Drug Control Strategy (2022) from the White House Office of National Drug Control Policy (ONDCP) lays out a comprehensive plan to, not only enhance access to treatment and increase harm reduction strategies, but also increase implementation of evidence-based prevention programming at the community level. Furthermore, the Strategy provides a framework for enhancing our national data systems to inform policy and to evaluate all components of the plan. However, not only are there several missing components to the Strategy that would assure its success, but there is a lack of structure to support a national comprehensive service delivery system that is informed by epidemiological data, and trains and credentials those delivering evidence-based prevention, treatment, and harm reduction/public health interventions within community settings. This paper provides recommendations for the establishment of such a structure with an emphasis on prevention. Systematically addressing conditions known to increase liability for behavioral problems among vulnerable populations and building supportive environments are strategies consistently found to avert trajectories away from substance use in general and substance use disorders (SUD) in particular. Investments in this approach are expected to result in significantly lower rates of SUD in current and subsequent generations of youth and, therefore, will reduce the burden on our communities in terms of lowered social and health systems involvement, treatment needs, and productivity. A national strategy, based on strong scientific evidence, is presented to implement public health policies and prevention services. These strategies work by improving child development, supporting families, enhancing school experiences, and cultivating positive environmental conditions. Appeared originally in Clin Child Fam Psychol Rev 2023; 26:1-16.

白宫国家毒品控制政策办公室(ONDCP)最近发布的《国家毒品控制战略》(2022 年)提出了一项全面计划,不仅要增加治疗机会,加强减少伤害战略,还要在社区层面加强循证预防计划的实施。此外,该战略还为加强我们的国家数据系统提供了一个框架,以便为政策提供信息并对计划的所有组成部分进行评估。然而,该战略不仅缺少确保其成功的几个组成部分,而且缺少支持国家综合服务提供系统的结构,该系统以流行病学数据为依据,对在社区环境中提供以证据为基础的预防、治疗和减少伤害/公共卫生干预措施的人员进行培训和资格认证。本文就建立这样一个以预防为重点的机构提出了建议。系统性地解决已知会增加弱势群体行为问题责任的条件,并建立支持性环境,这些策略被一致认为可以避免药物使用,尤其是药物使用失调(SUD)。对这一方法的投资有望大大降低当代和后代青少年的药物滥用率,从而减轻社区在社会和卫生系统参与、治疗需求和生产力方面的负担。在强有力的科学证据基础上,提出了一项国家战略,以实施公共卫生政策和预防服务。这些战略通过改善儿童发展、支持家庭、增强学校体验和培养积极的环境条件来发挥作用。原载于《临床儿童家庭心理学家评论》(Clin Child Fam Psychol Rev 2023; 26:1-16)。
{"title":"A National Strategy for Preventing Substance and Opioid Use Disorders Through Evidence-Based Prevention Programming That Fosters Healthy Outcomes in Our Youth.","authors":"Diana H Fishbein, Zili Sloboda","doi":"10.1176/appi.focus.24022020","DOIUrl":"10.1176/appi.focus.24022020","url":null,"abstract":"<p><p>The recently released National Drug Control Strategy (2022) from the White House Office of National Drug Control Policy (ONDCP) lays out a comprehensive plan to, not only enhance access to treatment and increase harm reduction strategies, but also increase implementation of evidence-based prevention programming at the community level. Furthermore, the Strategy provides a framework for enhancing our national data systems to inform policy and to evaluate all components of the plan. However, not only are there several missing components to the Strategy that would assure its success, but there is a lack of structure to support a national comprehensive service delivery system that is informed by epidemiological data, and trains and credentials those delivering evidence-based prevention, treatment, and harm reduction/public health interventions within community settings. This paper provides recommendations for the establishment of such a structure with an emphasis on prevention. Systematically addressing conditions known to increase liability for behavioral problems among vulnerable populations and building supportive environments are strategies consistently found to avert trajectories away from substance use in general and substance use disorders (SUD) in particular. Investments in this approach are expected to result in significantly lower rates of SUD in current and subsequent generations of youth and, therefore, will reduce the burden on our communities in terms of lowered social and health systems involvement, treatment needs, and productivity. A national strategy, based on strong scientific evidence, is presented to implement public health policies and prevention services. These strategies work by improving child development, supporting families, enhancing school experiences, and cultivating positive environmental conditions. Appeared originally in <i>Clin Child Fam Psychol Rev 2023; 26:1-16</i>.</p>","PeriodicalId":73036,"journal":{"name":"Focus (American Psychiatric Publishing)","volume":"22 4","pages":"527-542"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Focus (American Psychiatric Publishing)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1